APA (7th ed.) Citation

Roussos Torres, E., Ho, W. J., Danilova, L., Tandurella, J. A., Leatherman, J., Rafie, C., . . . Connolly, R. M. (2024). Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer. Nature Cancer, 5(6), 866-879. https://doi.org/10.1038/s43018-024-00729-w

Chicago Style (17th ed.) Citation

Roussos Torres, Evanthia.T., et al. "Entinostat, Nivolumab and Ipilimumab for Women with Advanced HER2-negative Breast Cancer." Nature Cancer 5, no. 6 (2024): 866-879. https://doi.org/10.1038/s43018-024-00729-w.

MLA (9th ed.) Citation

Roussos Torres, Evanthia.T., et al. "Entinostat, Nivolumab and Ipilimumab for Women with Advanced HER2-negative Breast Cancer." Nature Cancer, vol. 5, no. 6, 2024, pp. 866-879, https://doi.org/10.1038/s43018-024-00729-w.